On November 26 2024 Oncternal Therapeutics was traded for 0.71 at the closing time. The top price for the day was 0.84 and the lowest listed price was 0.62 . There was no trading activity during the period 0.0. Lack of trading volume on November 26, 2024 did not cause price change. The trading delta at closing time against the current closing price is 16.90% .
The median price is the midpoint of the trading periods range.
Other Forecasting Options for Oncternal Therapeutics
For every potential investor in Oncternal, whether a beginner or expert, Oncternal Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oncternal Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oncternal. Basic forecasting techniques help filter out the noise by identifying Oncternal Therapeutics' price trends.
Oncternal Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Oncternal Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Oncternal Therapeutics' current price.
Market strength indicators help investors to evaluate how Oncternal Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncternal Therapeutics shares will generate the highest return on investment. By undertsting and applying Oncternal Therapeutics stock market strength indicators, traders can identify Oncternal Therapeutics entry and exit signals to maximize returns.
The analysis of Oncternal Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oncternal Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oncternal stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
When running Oncternal Therapeutics' price analysis, check to measure Oncternal Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncternal Therapeutics is operating at the current time. Most of Oncternal Therapeutics' value examination focuses on studying past and present price action to predict the probability of Oncternal Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncternal Therapeutics' price. Additionally, you may evaluate how the addition of Oncternal Therapeutics to your portfolios can decrease your overall portfolio volatility.